SR-008

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameSR-008

Drug Alias NamesiRNA therapy (CSPC Pharmaceutical/Hebei Medical University)siRNA therapy (CSPC Zhongqi Pharmaceutical Technology/Hebei Medical University)SR-008

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionVirus replication inhibitors

TargetsUpdating

Therapy Area/IndicationsHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesHebei Medical University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHebei Medical University CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd

Active IndicationsN/A

Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A